Navigation Links
Vaccine Stops Alzheimer's Brain 'Tangles'
Date:8/21/2007

In mouse study, it prevented buildup of dangerous tau protein

TUESDAY, Aug. 21 (HealthDay News) -- A vaccine designed to combat a protein implicated in Alzheimer's disease has proven effective in mice, U.S. scientists say.

Abnormal tau protein accumulates into damaging tangles in the memory center of the brains of Alzheimer's patients, noted a team at the New York University Medical Center (NYUMC).

However, the new NYUMC-developed vaccine prevented tau tangles in several regions of the central nervous system of mice that were genetically engineered to produce abnormal tau proteins.

The vaccine prompted the immune system to produce antibodies that could enter the brain and bind to abnormal tau, the researchers said. This prevented tau from forming harmful tangles and causing motor coordination problems in the mice.

The study, which is published in the Aug. 22 issue of the Journal of Neuroscience, is the first to show that a vaccine can induce the immune system to combat abnormal tau protein.

"This approach may have extensive therapeutic implications, because you can specifically target the problematic protein," team leader Einar Sigurdsson, assistant professor of psychiatry and pathology, said in a prepared statement.

"Tau aggregates are inside the cell, making it especially difficult to develop a therapy to target and clear them from the cell," Sigurdsson noted.

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.



-- Robert Preidt



SOURCE: New York University Medical Center, news release, Aug. 22, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. New hope for cancer victims – will vaccine cure the deadly bug
4. Vaccine for Alzheimer’s diseas
5. New vaccine helps allergy and asthma patients
6. Man against HIV – new vaccine ready for human trials
7. New vaccine helps allergy and asthma patients
8. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
9. HIV did not arise from polio vaccine
10. Double impact vaccine
11. Health Officials Recommend Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2008)... Open enrollment is now h...s cover expenses not covered by Medicare, and may ...any consumers are now shopping online for instant ... Fort Collins, CO (PRWEB) November 21, 2008 -- Me...ent for Medicare Supplement plans . Medicare Adv...
(Date:11/21/2008)...Finding may lead to new therapies for preterm labo...- Researchers say they,ve found the switch that ac... childbirth, a finding that may lead to therapies ... normally binds the protein IP on the surface of t... inactive during pregnancy. , But researchers ...
(Date:11/21/2008)..., TALLAHASSEE, Fla. -- A Florida State Universit...g Wang has discovered an important new layer of re...ead to a greater understanding of the way cancer b...cal sciences at the College of Medicine, said the ...ose cancer and could lead to the design of new dru...
(Date:11/21/2008)...LOVELAND, Colo., Nov. 21 ...ced it will present at the New York Society of,Se... Pharma Conference on,December 2, 2008 at 1177 Av...The presentation is scheduled to begin at 9:35 a.m... be available via live webcast and for two weeks,...
Breaking Medicine News(10 mins):Health News:MediGap Advisors Announces Open Enrollment for Medicare Supplement Plans 2
...pical cyclone Glenda has increased the spread of t...y Valley encephalitis// (MVE), in Western Australi... wet season in Kimberley has spread the virus that.... The cyclone Glenda along with the more recent cy...
...earcher, Professor Ian Frazer of the University of... Premier's Fellowship. The prestigious Fellowship ...r award for his work in developing a vaccine for c...ellowship, Professor Ian Frazer will get $250,000 ...
...eo game makers are now looking to extend their rea...tele is concerned. And a really ripe market awaits... to "Brain Train" concept like a duck to water.// ...s sold 3.3 million of its "Brain Training for Adul...
...ording to a senior Guangdong health official of Ch...this year's peak human bird flu season in the prov...de by other health specialists. The senior health...rector of the Guangdong Centre for Disease Control...
Other Medicine News:
(Date:11/19/2008)...e/ -- Biotech scientists increasingly are applying...etter understand the effects of novel drug candida...c Engineering & Biotechnology News ( GEN ). T...w compound,s mechanism of action and eventually de...ing to the November 15 issue of GEN . ( http://ww...
(Date:11/18/2008)...n more, make a donation or send a Christmas Seals ...USNewswire/ -- Millions will receive Christmas Sea...n Lung Association. These decorative holiday stamp...ng back to 1907 when the Lung Association led effo...ericans alive today have no vivid memories of how ...
(Date:11/18/2008)...gnosed, elderly AML patients , , PRINCETON,...cals today announced that the first patient has be...of CPX-351 (Cytarabine:Daunorubicin) Liposome Inje...id leukemia (AML). , , The first patient wa...al College of Cornell University and New York Pre...
(Date:11/12/2008)...wswire/ -- A new study being,published in this Fri...question, what causes Parkinson,s disease?, One o...rch into,Parkinson,s disease is what causes the se...ce. Answering this question has been especially di...es of brain cells that produce,dopamine and they a...
Breaking Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3A Window Into Parkinson's Disease 2LaVoie Group Adds Cancer Therapeutics Company Neotropix 28R 29 to Its Life Science Agency Roster 26846 1LaVoie Group Adds Cancer Therapeutics Company Neotropix 28R 29 to Its Life Science Agency Roster 26846 2Covance Decides to Pursue Its Original Preclinical Strategy in China 7954 1Covance Decides to Pursue Its Original Preclinical Strategy in China 7954 2Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 1Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 2Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 3Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 4Austin Dentistry Clinic Now Offers Certified Full Service Sedation Dentistry All Gain No Pain 26841 1Austin Dentistry Clinic Now Offers Certified Full Service Sedation Dentistry All Gain No Pain 26841 2
...ot Study Demonstrates 50% Survival in Valortim-Tre..., March 29, 2007,/PRNewswire-FirstCall/ -- Medarex...d PharmAthene, Inc., a privately held,biotechnolog...se,countermeasures, today announced that Valortim(...didate being developed for the,prevention and trea...
...trations Reached in Key Lung Compartments, REINACH...e-FirstCall/ -- Arpida Ltd. today announced promis... These radiolabelled,Human Microdose studies inclu...groundbreaking study is the first ever using Micro...s in lung compartments.,The results showed that AR...
Other Medicine Technology:Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 8Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 2Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 3Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 5
Low-profile, hand-held instrument.
Low-profile, hand-held instrument.
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries.
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries.
Medicine Products: